发明名称 IMPROVED TARGET LIGAND DETECTION
摘要 <p>The present invention provides compositions, devices and methods suitable for the increased sensitivity and selectivity of binding assays thereby reducing false positive results without little or no reduction in the detection of true positives. The present invention is based on the novel discovery that an oxidative agent in the context of the device of the present invention results in decreased false positive reactivity with little or no reduction in true positive reactivity. The devices, compositions and methods of the present invention may be used, for example, to detect pathogens giving rise to endogenous urine antibodies include those organisms known to be causative agents in sexually-transmitted diseases and other diseases. The devices and methods of the present invention are also useful for various diagnostic procedures.</p>
申请公布号 WO2007047924(A2) 申请公布日期 2007.04.26
申请号 WO2006US41037 申请日期 2006.10.19
申请人 CALYPTE BIOMEDICAL CORPORATION 发明人 GOTTFRIED, TOBY
分类号 G01N33/543 主分类号 G01N33/543
代理机构 代理人
主权项
地址